B2V2T4 AF NFT

Tryptophan synthase beta chain

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidjev6zatcqvedklbct3tkkmazdnefi2z64rdo5somciqfaltewia/metadata.json
IPFS of structure file: 
bafybeifnzeo6utre4hd2erm4urres3wsu66rzz6qf3rdkwu6ym4z2l2bba/AF-B2V2T4-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd10960F956646DE8b64d3598984c91C2d5Af3D7b
First NFT owner address (bech32): 
genesis16yykp72kv3k73djdxkvfsny3ct2670tm7h5hjv
Current NFT ID #476408 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
476408
Accession (UniProt):
B2V2T4
Name::
Tryptophan synthase beta chain
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V2T4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V2T4|TRPB_CLOBA Tryptophan synthase beta chain OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=trpB PE=3 SV=1 MDFRTYLKRYPDKNGRFGQYGGAYLTNELIPAFEEIADAYQTICHSSQFISELRRIRKEFQGRPTPVYHCERLSRAIGNCQIYLKREDLNHTGAHKLNHCMGEGLLAKFMGKKRLIAETGAGQHGVALATAAAFFGLECEIHMGEVDIAKQAPNVTRMKILGAKVVPVTHGLKTLKEAVDSAFDSYAKNYKDSIYCIGSALGPHPFPLMVRDFQAVVGYEAKDQFKEMTGFLPDVVTACVGGGSNAAGMFIPFLEEPVDIIGIEPLGRGEKLGDHAASMKYGEKGVMHGFESIMLKDKNGNPAPVYSIASGLDYPSVGPEHAFLRELGRVDYKVINDEEAMEAFFKLSRYEGIIPAIESSHAVAYAMKKAKEMKQGSILVCLSGRGDKDIDYVVEHYGYGEQYFK